About the company
İLKO İlaç is a Turkish pharmaceutical company within Selçuklu Holding. Its industrial heritage is linked to pharmacist Mustafa Öncel’s work preparing medicines in a pharmacy in the 1960s and his subsequent investments in pharmaceuticals. İLKO continues this experience through modern manufacturing and scientific research.
The company brings together prescription medicines, consumer healthcare and biotechnology. Its production complex in Konya, the İLKO ARGEM research centre and dedicated biotechnology development capabilities are key parts of its operations.
Key areas of activity
İLKO’s medicine portfolio covers cardiology, central nervous system conditions, rare diseases and acute conditions. In consumer healthcare, its Wellcare brand includes categories such as digestive health, probiotics, vitamins and minerals, reflecting a portfolio that extends beyond prescription medicines.
Biotechnology activities include İlkogen, established with South Korea’s Genexine, and a dedicated research centre. Alongside the development of new products, İLKO’s business encompasses manufacturing partnerships, international registration and exports. Together, these activities connect research expertise with production capacity and collaboration in international markets.
Partnership with Zeytun
İLKO İlaç is among the strategic and commercial partners of Zeytun Pharmaceuticals. This cooperation forms part of our international partnership portfolio. For further information about the partnership and related products, please contact the Zeytun Pharmaceuticals team.